Arshad Ali Khan

Arshad Ali Khan is a Research Scientist at Oxalo Therapeutics, Inc., since July 2022. Prior to this role, Arshad worked as a Postdoctoral Research Associate at the University of Virginia from June 2019 to May 2021 and as a Senior Lecturer at Universiti Malaysia Pahang from July 2017 to January 2019. Experience also includes serving as a Research Scholar at Universiti Sains Malaysia from April 2012 to May 2017, and holding positions in regulatory affairs and formulation development at Accure Labs Pvt Ltd. and Fresenius Kabi, respectively. Arshad holds a Doctor of Philosophy (PhD) in Pharmaceutical Technology from Universiti Sains Malaysia, a Master of Pharmacy (M.Pharm) in Pharmaceutics- Quality Assurance from Jamia Hamdard, and a Bachelor of Pharmacy (B.Pharm) in Pharmaceutical Sciences, also from Jamia Hamdard.